The Jerusalem PostBritish Council allocates 1.5m pound fund to joint Israeli stem cell researchThe Jerusalem PostUK and Israeli research institutions will work together on four new, three-year bilateral projects in the use of stem cells to tackle degen… Continue reading
The Jerusalem PostBritish Council allocates 1.5m pound fund to joint Israeli stem cell researchThe Jerusalem PostUK and Israeli research institutions will work together on four new, three-year bilateral projects in the use of stem cells to tackle degen… Continue reading
MedscapeOmalizumab improves efficacy of oral immunotherapy for multiple …Pharmacy Today, American Pharmacists Association, pharmacist.comCombining a 16-week initial course of the medication omalizumab with oral immunotherapy (OIT) greatly improves th… Continue reading
Chemical & Engineering News |
CRISPR gene editing moved into humans in 2017
Science News Whether scientists should use CRISPR/Cas9’s power to create gene-edited babies is a matter of heated debate. Until March, the battles were mostly academic because previous attempts to edit human embryos were done in embryos that would never develop … If CRISPR is so amazing, why can’t we edit human genes yet … – ABCABC Online CRISPR gene editing is coming to the clinicChemical & Engineering News Genetic Differences Could Impact Efficacy and Safety of CRISPRGenetic Engineering & Biotechnology News Nature.com –EurekAlert (press release) all 38 news articles » |
Science News |
Approval of gene therapies for two blood cancers led to an ‘explosion of interest’ in 2017
Science News The U.S. Food and Drug Administration approved two personalized treatments that engineer a patient’s own immune system to hunt down and kill cancer cells. The treatments, the first gene therapies ever approved by the FDA, work in people with certain … |
Science News |
Approval of gene therapies for two blood cancers led to an ‘explosion of interest’ in 2017
Science News The U.S. Food and Drug Administration approved two personalized treatments that engineer a patient’s own immune system to hunt down and kill cancer cells. The treatments, the first gene therapies ever approved by the FDA, work in people with certain … |